
    
      This is a double-blind, placebo-controlled, bilateral, ascending dose study.

      In vitro, fluphenazine has been shown to suppress growth of proliferating T-lymphocytes.
      Fluphenazine would be expected to also suppress growth of proliferating T-lymphocytes in
      psoriatic plaques.
    
  